In Trading, Results Matter.
Our Top 10 exits in last 5 trading days.

Globus Medical, Inc.. Trade Record

NYSE:GMED Globus Medical, Inc. stock gains 15.99% Exit Dec 1, 2017 a Trade Record by priceseries

Trade Chart
Trade Chart GMED Nov 8, 2017, priceSeries
About Globus Medical, Inc.

Globus Medical, Inc., a medical device company, focuses on the design, development, and commercialization of musculoskeletal implants that promote healing in patients with spine disorders. The company offers products that address an array of spinal pathologies, anatomies, and surgical approaches. It provides fusion products that are used in cervical, thoracolumbar, sacral, and interbody/corpectomy fusion procedures to treat degenerative, deformity, tumor, and trauma conditions. The company also offers various disruptive technology products that provide material improvements to fusion procedures, such as minimally invasive surgical techniques, as well as new treatment alternatives, which include motion preservation technologies comprising dynamic stabilization, total disc replacement, and interspinous process spacer products; regenerative biologics technologies; and interventional pain management solutions, including treatments for vertebral compression fractures. In addition, it offers human tissue products, such as bone allografts, biomaterials, and soft tissue products for spine, orthopedics, sports medicine, dental, and wound care markets. The company sells its implants and related disposables primarily to hospitals through direct sales representatives and independent distributors in the United States and internationally. Globus Medical, Inc. was founded in 2003 and is headquartered in Audubon, Pennsylvania.

Trade Information
Trade Type
LONG
ReliabilityScore™
94.67
Entry Date
Nov 8, 2017
Entry Price
31.84
Sell Date
Dec 1, 2017
Sell Price
36.93
Net Gain
15.99%
Hold Time
16 Trading Days